Key result
Myocarditis affects ~3% of patients with antisynthetase syndrome, with most achieving full recovery.
Why the study?
Myocardial involvement in antisynthetase syndrome is poorly described, necessitating characterization of myocarditis prevalence and features in this condition.
What is the prevalence, clinical presentation, and prognosis of myocarditis in patients with antisynthetase syndrome?
Observational (n=352)
What is the prevalence, clinical presentation, and prognosis of myocarditis in patients with antisynthetase syndrome?
Myocarditis is a severe but relatively rare (3.4%) manifestation in active antisynthetase syndrome that generally has a good prognosis with immunosuppressive therapy.
Answers are grounded in this paper and cite their sources.
Myocarditis warrants consideration in aSS with troponin elevation; hypothesis-generating and should not yet change practice.
Antisynthetase syndrome (aSS) corresponds to an overlapping inflammatory myopathy identified by various myositis-specific autoantibodies (directed against tRNA-synthetases). Myocardial involvement in this condition is poorly described.From a registry of 352 aSS patients, 12 cases of myocarditis were retrospectively identified on the basis of an unexplained increase in troponin T/I levels associated with either suggestive cardiac magnetic resonance imaging (MRI) findings, nonsignificant coronary artery abnormalities or positive endomyocardial biopsy.The prevalence of myocarditis in aSS is 3.4% and was not linked to any autoantibody specificity: anti-Jo1 (n = 8), anti-PL7 (n = 3), and anti-PL12 (n = 1). Myocarditis was a part of the first aSS manifestations in 42% of the cases and was asymptomatic (n = 2) or revealed by an acute (n = 4) or a subacute (n = 6) cardiac failure. It should be noted that myocarditis was always associated with an active myositis. When performed (n = 11), cardiac MRI revealed a late hypersignal in the T1-images in 73% of the cases (n = 8). Half of the patients required intensive care. Ten patients (83%) received dedicated cardiotropic drugs. Steroids and at least 1 immunosuppressive drug were given in all cases. After a median follow-up of 11 months (range 0-84) 9 (75%) patients recovered whereas 3 (25%) developed a chronic cardiac insufficiency. No patient died.The prevalence of myocarditis in aSS is similar to that of other inflammatory myopathies. Although the prognosis is relatively good, myocarditis is a severe condition and should be carefully considered as a possible manifestation in active aSS patients.
No takes yet. Share an insight, caveat, or question.
Dieval et al. (2015) conducted an observational in Antisynthetase syndrome (n=352). Antisynthetase syndrome was evaluated on Prevalence of myocarditis. In a registry of 352 patients with antisynthetase syndrome, the prevalence of myocarditis was 3.4%, with 75% of affected patients recovering after a median follow-up of 11 months.
Synapse has enriched 10 related papers. Consider them for comparative context: